article Open AccessTop 1% cited
Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism
Nephrology Dialysis Transplantation · 1998 · Vol. 13(8) · pp. 2037–2040
Silvia Carreira Ribeiro✉(Clinica De Doencas Renais De Brasilia)
Abstract
Our study confirmed an increased prevalence of VC in HD patients and selected age and calcium phosphate product as the most predictive parameters. These findings support careful monitoring of calcium metabolism beginning at the early stages of end-stage renal failure to reduce the risk of heart disease.
Advanced X-ray and CT ImagingInfective Endocarditis Diagnosis and ManagementCardiac Valve Diseases and TreatmentsMedicineCalcificationInternal medicineCardiologyHemodialysisKidney diseaseDialysisCalciumCalcinosis
MeSH terms
AgedCalcinosisCalciumEchocardiographyFemaleHeart Valve DiseasesRenal DialysisHumansHypertensionMaleMiddle AgedPhosphatesReference ValuesVascular DiseasesPrevalence
Citations
332
FWCI
12.13
field-weighted impact
References
8
Percentile
99%
vs. same field & year
Citations per year
Cited by
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
American Journal of Kidney Diseases · 2005 · 1,426 citations
Bone metabolism and disease in chronic kidney disease
American Journal of Kidney Diseases · 2003 · 1,261 citations
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management
American Journal of Kidney Diseases · 2000 · 595 citations
Lower risk for cardiovascular mortality in oral 1 -hydroxy vitamin D3 users in a haemodialysis population
Nephrology Dialysis Transplantation · 2003 · 352 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.